Monoclonal Antibodies

Monoclonal antibody treatments can be used in people 12 years of age and older who weigh at least 88 pounds who are at high risk for severe COVID-19.

To be eligible, patients must: 

• Test positive for SARS-CoV-2.
• Be within 10 days of the start of their symptoms.
• Not be hospitalized.
• Have had close contact or are at high risk of being in close contact with someone with COVID-19, such as people in the same institutional setting (for example, nursing homes or prisons). where COVID-19 is circulating.

Antibodies can be given by intravenous infusion or by subcutaneous injection. Antibodies may be administered ONLY in settings where healthcare providers have immediate access to medications to treat any reactions and where emergency medical systems are available, if needed.

Monoclonal antibody treatments are allowed by the US Food and Drug Administration (FDA) under an emergency use authorization (EUA) while clinical studies continue to look at their usefulness and safety.

Talk to your doctor or other health care provider about treatments that are right for you, including if you have other medical conditions that are not listed above.